Healthcare Global Enterprises enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
8,511————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
536536236273175
78.278.267.639.38.9
9109101,002673399
8,964————
374374766400225
₹622.90————
2,3212,3211,9921,5381,269
39.2%39.2%50.3%43.7%31.5%
0.10×————
3.41×————
18.66×————
40.09×————
162.97×————
Reference items — trailing FY values
2,6272,5452,2231,9121,694
480466387330299
224222176155135
—347317285252
55.055.010898.9118
—41.697.272.889.6
—292209186133
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HCG₹591.45

Healthcare Global Enterprises Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISRAINBOWJLHLCORONAMARKSANSMETROPOLISPARKHOSPSMcap ₹8,511 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————8,511.0
- Cash, Equiv & ST Investments174.6272.6235.9536.1536.1
+ Minority Interest8.939.367.678.278.2
+ Total Debt399.3672.81,002.2910.4910.4
Enterprise Value————8,963.6
Net Debt (memo)224.7400.2766.4374.4374.4
EV per Share————622.90
Total Capital1,268.81,537.91,992.32,320.62,320.6
Total Debt/Total Capital31.4743.7550.3139.2339.23
Total Debt/EV————0.10
EV/Sales————3.41
EV/EBITDA————18.66
EV/EBIT————40.09
EV/Free Cash Flow————162.97
Reference Items — Trailing FY Values
Sales1,694.41,912.12,222.92,545.42,627.4
EBITDA298.7329.6387.3465.8480.3
EBIT135.2155.2175.9221.6223.6
Operating Cash Flow251.6284.6317.1347.1—
Free Cash Flow118.498.9108.355.055.0
FCFF (free cash flow to the firm)89.672.897.241.6—
Capital Expenditure133.2185.7208.9292.1—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.